[Treatment with deflazacort associated with a thyrostatic therapy in a case of juvenile Basedow's ophthalmopathy. Clinical and hematochemical evaluation of therapeutic results].
In this brief report we describe a case of juvenile Basedow disease associated which exophthalmus and treated with deflazacort and methimazole on the basis of its immune origin (as confirmed by the presence of high levels of antimicrosomal antibodies). After only two months of therapy, we already noted a definite reduction of the exophthalmus and normalization of the thyroid hormone parameters with disappearance of the antimicrosomal antibodies.
Letizia
C
C
Sellini
M
M
Di Palma
L
L
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006111:Graves Disease / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008713:Methimazole / Q000008:administration & dosage*; D011282:Pregnenediones / Q000008:administration & dosage*; D013963:Thyroid Hormones / Q000097:blood
D000893:Anti-Inflammatory Agents; D011282:Pregnenediones; D013963:Thyroid Hormones; D008713:Methimazole; C021988:deflazacort
Trattamento con deflazacort associato a terapia tireostatica in un caso di oftalmopatia basedowiana giovanile. Valutazione clinica ed ematochimica dei risultati terapeutici.